Dream-enactment behaviours during the COVID-19 pandemic: an international COVID-19 sleep study

There has been increasing concern about the long-term impact of coronavirus disease 2019 (COVID-19) as evidenced by anecdotal case reports of acute-onset parkinsonism and the polysomnographic feature of increased rapid eye movement sleep electromyographic activity. This study aimed to determine the prevalence and correlates of dream-enactment behaviours, a hallmark of rapid eye movement sleep behaviour disorder, which is a prodrome of α-synucleinopathy. This online survey was conducted between May and August 2020 in 15 countries/regions targeting adult participants (aged ≥18 years) from the general population with a harmonised structured questionnaire on sleep patterns and disorders, COVID-19 diagnosis and symptoms. We assessed dream-enactment behaviours using the Rapid Eye Movement Sleep Behaviour Disorder Single-Question Screen with an additional question on their frequency. Among 26,539 respondents, 21,870 (82.2%) answered all items that were analysed in this study (mean [SD] age 41.6 [15.8] years; female sex 65.5%). The weighted prevalence of lifetime and weekly dream-enactment behaviours was 19.4% and 3.1% and were found to be 1.8- and 2.9-times higher in COVID-19-positive cases, respectively. Both lifetime and weekly dream-enactment behaviours were associated with young age, male sex, smoking, alcohol consumption, higher physical activity level, nightmares, COVID-19 diagnosis, olfactory impairment, obstructive sleep apnea symptoms, mood, and post-traumatic stress disorder features. Among COVID-19-positive cases, weekly dream-enactment behaviours were positively associated with the severity of COVID-19. Dream-enactment behaviours are common among the general population during the COVID-19 pandemic and further increase among patients with COVID-19. Further studies are needed to investigate the potential neurodegenerative effect of COVID-19

Gelatin-based microspheres crosslinked with glutaraldehyde and rutin oriented to cosmetics

ABSTRACT Glutaraldehyde (GTA) has been extensively used as a gelatin crosslinking agent, however, new natural ones have been suggested as more biocompatible. Polyphenols are possible candidates and the flavonols, such as rutin (RUT), also exhibit potential synergism with sunscreens and antioxidant agents used in cosmetics. In this work, gelatin microspheres (M0) were obtained and crosslinked with GTA 10 mM (MG) or RUT 10 mM (MR), dissolved in acetone:NaOH 0,01M (70:30 v/v). MG exhibited crosslinking extent of 54.4%. Gelatin, M0, MG and MR did not elicit any signs of skin damage, regarding the formation of erythema, the barrier function disruption and negative interference in the stratum corneum hydration. Oily dispersions containing M0, MG or MR, isolated or combined with benzophenone-3 or octyl methoxycinnamate, suggested that the microspheres, at a 5.0% w/w, had no additional chemical or physical photoprotective effect in vitro. Crosslinking with RUT had occurred, but in a lower degree than GTA. Microspheres had not improved sun protection parameters, although, non-treated gelatin interfered positively with the SPF for both UV filters. The in vivo studies demonstrated that these materials had very good skin compatibility

NEOTROPICAL XENARTHRANS: a data set of occurrence of xenarthran species in the Neotropics

Xenarthrans – anteaters, sloths, and armadillos – have essential functions for ecosystem maintenance, such as insect control and nutrient cycling, playing key roles as ecosystem engineers. Because of habitat loss and fragmentation, hunting pressure, and conflicts with 24 domestic dogs, these species have been threatened locally, regionally, or even across their full distribution ranges. The Neotropics harbor 21 species of armadillos, ten anteaters, and six sloths. Our dataset includes the families Chlamyphoridae (13), Dasypodidae (7), Myrmecophagidae (3), Bradypodidae (4), and Megalonychidae (2). We have no occurrence data on Dasypus pilosus (Dasypodidae). Regarding Cyclopedidae, until recently, only one species was recognized, but new genetic studies have revealed that the group is represented by seven species. In this data-paper, we compiled a total of 42,528 records of 31 species, represented by occurrence and quantitative data, totaling 24,847 unique georeferenced records. The geographic range is from the south of the USA, Mexico, and Caribbean countries at the northern portion of the Neotropics, to its austral distribution in Argentina, Paraguay, Chile, and Uruguay. Regarding anteaters, Myrmecophaga tridactyla has the most records (n=5,941), and Cyclopes sp. has the fewest (n=240). The armadillo species with the most data is Dasypus novemcinctus (n=11,588), and the least recorded for Calyptophractus retusus (n=33). With regards to sloth species, Bradypus variegatus has the most records (n=962), and Bradypus pygmaeus has the fewest (n=12). Our main objective with Neotropical Xenarthrans is to make occurrence and quantitative data available to facilitate more ecological research, particularly if we integrate the xenarthran data with other datasets of Neotropical Series which will become available very soon (i.e. Neotropical Carnivores, Neotropical Invasive Mammals, and Neotropical Hunters and Dogs). Therefore, studies on trophic cascades, hunting pressure, habitat loss, fragmentation effects, species invasion, and climate change effects will be possible with the Neotropical Xenarthrans dataset

Disturbances in sleep, circadian rhythms and daytime functioning in relation to coronavirus infection and Long-COVID – A multinational ICOSS study

This protocol paper describes the second survey produced by the International Covid Sleep Study (ICOSS) group with the aim to examine the associations between SARS-CoV-2 infection and sleep, sleepiness, and circadian problems as potential predisposing factors for more severe COVID-19 disease profile and for development of Long-COVID in the general population. The survey consists of 47 questions on sleep, daytime sleepiness, circadian rhythm, health, mental wellbeing, life habits, and socioeconomic situation before and during the pandemic, and conditional questions to those reporting having had coronavirus infection, being vaccinated, or suffering from particular sleep symptoms or sleep disorders. Surveys will be administered online between May and November 2021 in Austria, Brazil, Bulgaria, Canada, China, Croatia, Finland, France, Germany, Israel, Italy, Japan, Norway, Portugal, Sweden and USA. Data collected by the survey will give valuable information on the open questions regarding COVID-19 disease risk factors, symptomatology and evolution of Long-COVID, and on other long-term consequences related to the pandemic

Validação da escala de ritmo circadiano - ciclo vigília/sono para adolescentes Validación de la escala de ritmo circadiano - ciclo vigilia / sueño para adolescentes Validity of a circadian rhythm scale - sleep/wake cycle for adolescents

OBJETIVO: Validar a Escala Puberty and Phase Preference, de Carskadon, Vieira e Acebo (1993), traduzida para a língua portuguesa, que investiga os horários de acordar e dormir de adolescentes e seus sentimentos com relação a estes, denominando-os matutinos ou vespertinos. MÉTODOS: Participaram do estudo 144 alunos do ensino fundamental, 86 meninos e 58 meninas, com média de idade de 13,2±1,6 anos. A validade de constructo foi por critério preditivo. A escala de ritmo circadiano foi aplicada na sala de aula; após um mês de tal aplicação, os alunos foram solicitados a responder por sete dias consecutivos outro questionário. Este perguntava, referente ao dia anterior, o horário em que foi dormir e, referente ao próprio dia, o momento em que despertou. Para avaliar as evidências de validade de critério foram comparadas as médias por análise de variância one-way e teste post-hoc da diferença mínima significativa. RESULTADOS: As propriedades psicométricas da escala mostraram-se satisfatórias. A análise de consistência interna pelo alfa de Cronbach foi de 0,791. CONCLUSÕES: Os resultados indicaram fidedignidade e validade nas preferências de alocação do ciclo vigília e sono. Os índices foram significativos e direcionados aos horários esperados, evidenciando a validade da escala.<br>OBJETIVO: Validar la Escala Puberty and Phase Preference, de Carskadon, Vieira e Acebo (1993), traducida al portugués, que investiga los horarios de despertar y dormir de adolescentes y sus sentimientos respecto a esos horarios, nombrándolos matutinos o vespertinos. MÉTODOS: Participaron del estudio 144 alumnos de la primaria, 86 muchachos y 58 muchachas, con promedio de edad de 13,2±1,6 años. La validez de constructo fue por criterio predictivo. La escala de ritmo circadiano fue aplicada en el aula; después de un mes de esa aplicación, se solicitó que los alumnos contestaran, durante siete días consecutivos, a otro cuestionario. Éste preguntaba, referente al día anterior, el horario en que durmió y, referente al mismo día, el momento en que despertó. Para evaluación de las evidencias de validez de criterio, fueron realizados análisis de comparación de promedios con análisis de variancia one-way y prueba post-hoc de la diferencia mínima significativa. RESULTADOS: Las propiedades psicométricas de la escala se mostraron satisfactorias. El análisis de consistencia interna por el alpha de Cronbach fue de 0,791. CONCLUSIONES: Los resultados indicaron buena confiabilidad y validez en las preferencias de asignación del ciclo vigilia y sueño. Los índices fueron significativos y dirigidos a los horarios esperados, evidenciando la validez de la escala.<br>OBJECTIVE: To validate the Portuguese version of the Puberty and Phase Preference Scale, designed by Carskadon, Vieira and Acebo in 1993, which investigates the waking and sleeping time of adolescents and their feelings related to these habits, in order to classify them as morning or evening people. METHODS: The study included 144 elementary school students, 86 boys and 58 girls, aged 13.2±1.6 years-old. The construct was validated by a predictive criterion. The scale of the circadian rhythm was applied to the students in the classroom. One month later, for seven consecutive days, the students were asked to answer another questionnaire regarding the time they slept the day before and when they woke up on the next day. To evaluate the evidence of criterion validity, one-way variance analysis followed by the least significant difference post-hoc test were applied. RESULTS: The psychometric properties of the scale were satisfactory. The analysis of internal consistency by Cronbach's Alpha was 0.791. CONCLUSIONS: The results indicated good consistency and validity of the allocation preferences in the sleep/wake cycle. All indexes were significant and directed to the time expected, pointing out the scale validity

Insomnia, anxiety, and depression during the COVID-19 pandemic: an international collaborative study

Importance and study objective: The COVID-19 pandemic has produced unprecedented changes in social, work, and leisure activities, which all have had major impact on sleep and psychological well-being. This study documented the prevalence of clinical cases of insomnia, anxiety, and depression and selected risk factors (COVID-19, confinement, financial burden, social isolation) during the first wave of the pandemic in 13 countries throughout the world. Design and participants: International, multi-center, harmonized survey of 22 330 adults (mean age = 41.9 years old, range 18–95; 65.6% women) from the general population in 13 countries and four continents. Participants were invited to complete a standardized web-based survey about sleep and psychological symptoms during the first wave of the COVID-19 pandemic from May to August 2020. Results: Clinical insomnia symptoms were reported by 36.7% (95% CI, 36.0–37.4) of respondents and 17.4% (95% CI, 16.9–17.9) met criteria for a probable insomnia disorder. There were 25.6% (95% CI, 25.0–26.2) with probable anxiety and 23.1% (95% CI, 22.5–23.6) with probable depression. Rates of insomnia symptoms (&gt;40%) and insomnia disorder (&gt;25%) were significantly higher in women, younger age groups, and in residents of Brazil, Canada, Norway, Poland, USA, and United Kingdom compared to residents from Asian countries (China and Japan, 8% for disorder and 22%–25% for symptoms) (all Ps &lt; 0.01). Proportions of insomnia cases were significantly higher among participants who completed the survey earlier in the first wave of the pandemic relative to those who completed it later. Risks of insomnia were higher among participants who reported having had COVID-19, who reported greater financial burden, were in confinement for a period of four to five weeks, and living alone or with more than five people in same household. These associations remained significant after controlling for age, sex, and psychological symptoms. Conclusion and relevance: Insomnia, anxiety, and depression were very prevalent during the first wave of the COVID-19 pandemic. Public health prevention programs are needed to prevent chronicity and reduce long-term adverse outcomes associated with chronic insomnia and mental health problems